SEMA3F and ductal breast carcinoma in situ: Taken together, these results further corroborate our in vitro and in vivo data and reveal the importance of the SEMA3F/NRP1/NRP2 complex in the progression and acquisition of invasive features in DCIS lesions from bench to bedside (Fig. 8).